Information on natalizumab (marketed as Tysabri) FDA, 26 Apr 2011 Accessed on 21 Nov 2011 from http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107198.htm. CommentRecommendBookmarkWatch